antineoplastic agent protein kinase inhibitor gefitinib 2024-01-15T13:18:12Z CID:123631 MESH:D000077156 N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine This is any condition in which the main influencing factor is gefitinib, an EGFR (epidermal growth factor receptor) tyrosine kinase inhibitor used for the treatment of non-small cell lung cancer. XCO:0001239 ZD1839 experimental_condition_ontology slaulederkind